An NK and T cell enhancer lies 280 kilobase pairs 3' to the Gata3 structural gene

Molecular and Cellular Biology

Volumn 31, Issue 9, 2011, Pages 1894-1904

  Hosoya Ohmura, Sakie ^a   Lin, Yu Hsuan ^a   Herrmann, Mary ^a   Kuroha, Takashi ^a   Rao, Arvind ^a   Moriguchi, Takashi ^a,b   Lim, Kim Chew ^a   Hosoya, Tomonori ^a   Engel, James Douglas ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CIS ACTING ELEMENT; DNA; TRANSCRIPTION FACTOR GATA 3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE LOCUS; GENETIC TRANSCRIPTION; IN VIVO STUDY; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; STRUCTURAL GENE; T LYMPHOCYTE;

ANIMALS; ENHANCER ELEMENTS, GENETIC; GATA3 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION; GENE KNOCK-IN TECHNIQUES; KILLER CELLS, NATURAL; LEUKOPOIESIS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; T-LYMPHOCYTES;

EID: 79955364415     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.05065-11     Document Type: Article

References (54)

1. Amsen, D., et al. 2007. Direct regulation of Gata3 expression determines the T helper differentiation potential of Notch. Immunity 27:89-99.
2. Reference deleted.
3. Anderson, M. K., et al. 2002. Definition of regulatory network elements for T cell development by perturbation analysis with PU.1 and GATA-3. Dev. Biol. 246:103-121.
4. Asnagli, H., M. Afkarian, and K. M. Murphy. 2002. Cutting edge: identification of an alternative GATA-3 promoter directing tissue-specific gene expression in mouse and human. J. Immunol. 168:4268-4271.
5. Asselin-Labat, M.-L., et al. 2007. Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation. Nat. Cell Biol. 9:201-209.
6. Boyle, A. P., et al. 2008. High-resolution mapping and characterization of open chromatin across the genome. Cell 132:311-322.
7. Chen, D., and G. Zhang. 2001. Enforced expression of the GATA-3 transcription factor affects cell fate decisions in hematopoiesis. Exp. Hematol. 29:971-980.
8. Crawford, G. E., et al. 2006. DNase-chip: a high-resolution method to identify DNase I hypersensitive sites using tiled microarrays. Nat. Methods 3:503-509.
9. Crawford, G. E., et al. 2004. Identifying gene regulatory elements by genome-wide recovery of DNase hypersensitive sites. Proc. Natl. Acad. Sci. U. S. A. 101:992-997.
10. Crawford, G. E., et al. 2006. Genome-wide mapping of DNase hypersensitive sites using massively parallel signature sequencing (MPSS). Genome Res. 16:123-131.
11. David-Fung, E.-S., et al. 2006. Progression of regulatory gene expression states in fetal and adult pro-T-cell development. Immunol. Rev. 209:212- 236.
12. Fang, T. C., et al. 2007. Notch directly regulates Gata3 expression during T helper 2 cell differentiation. Immunity 27:100-110.
13. Fiering, S. N., et al. 1991. Improved FACS-Gal: flow cytometric analysis and sorting of viable eukaryotic cells expressing reporter gene constructs. Cytometry 12:291-301.
14. George, K. M., et al. 1994. Embryonic expression and cloning of the murine GATA-3 gene. Development 120:2673-2686.
15. Grigorieva, I. V., et al. 2010. Gata3-deficient mice develop parathyroid abnormalities due to dysregulation of the parathyroid-specific transcription factor Gcm2. J. Clin. Invest. 120:2144-2155.
16. Hasegawa, S. L., et al. 2007. Dosage-dependent rescue of definitive nephrogenesis by a distant Gata3 enhancer. Dev. Biol. 301:568-577.
17. Hendriks, R. W., et al. 1999. Expression of the transcription factor GATA-3 is required for the development of the earliest T cell progenitors and correlates with stages of cellular proliferation in the thymus. Eur. J. Immunol. 29:1912-1918.
18. Hernández-Hoyos, G., M. K. Anderson, C. Wang, E. V. Rothenberg, and J. Alberola-Ila. 2003. GATA-3 expression is controlled by TCR signals and regulates CD4/CD8 differentiation. Immunity 19:83-94.
19. Hosoya, T., et al. 2009. GATA-3 is required for early T lineage progenitor development. J. Exp. Med. 206:2987-3000.
20. Hosoya, T., I. Maillard, and J. D. Engel. 2010. From the cradle to the grave: activities of GATA-3 throughout T-cell development and differentiation. Immunol. Rev. 238:110-125.
21. Kaufman, C. K., et al. 2003. GATA-3: an unexpected regulator of cell lineage determination in skin. Genes Dev. 17:2108-2122.
22. Khandekar, M., N. Suzuki, J. Lewton, M. Yamamoto, and J. D. Engel. 2004. Multiple, distant Gata2 enhancers specify temporally and tissue-specific patterning in the developing urogenital system. Mol. Cell. Biol. 24:10263-10276.
23. Ko, L. J., et al. 1991. Murine and human T-lymphocyte GATA-3 factors mediate transcription through a cis-regulatory element within the human T-cell receptor delta gene enhancer. Mol. Cell. Biol. 11:2778-2784.
24. Kouros-Mehr, H., E. M. Slorach, M. D. Sternlicht, and Z. Werb. 2006. GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland. Cell 127:1041-1055.
25. Kurek, D., G. A. Garinis, J. H. van Doorninck, J. van der Wees, and F. G. Grosveld. 2007. Transcriptome and phenotypic analysis reveals Gata3-dependent signalling pathways in murine hair follicles. Development 134:261- 272.
26. Lakshmanan, G., K. H. Lieuw, F. Grosveld, and J. D. Engel. 1998. Partial rescue of GATA-3 by yeast artificial chromosome transgenes. Dev. Biol. 204:451-463.
27. Lakshmanan, G., et al. 1999. Localization of distant urogenital system-, central nervous system-, and endocardium-specific transcriptional regulatory elements in the GATA-3 locus. Mol. Cell. Biol. 19:1558-1568.
28. Lee, E. C., et al. 2001. A highly efficient Escherichia coli-based chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA. Genomics 73:56-65.
29. Lieuw, K. H., G. Li, Y. Zhou, F. Grosveld, and J. D. Engel. 1997. Temporal and spatial control of murine GATA-3 transcription by promoter-proximal regulatory elements. Dev. Biol. 188:1-16.
30. Lim, K. C., et al. 2000. Gata3 loss leads to embryonic lethality due to noradrenaline deficiency of the sympathetic nervous system. Nat. Genet. 25:209-212.
31. Maurice, D., J. Hooper, G. Lang, and K. Weston. 2007. c-Myb regulates lineage choice in developing thymocytes via its target gene Gata3. EMBO J. 26:3629-3640.
32. Moriguchi, T., et al. 2006. Gata3 participates in a complex transcriptional feedback network to regulate sympathoadrenal differentiation. Development 133:3871-3881.
33. Nawijn, M. C., et al. 2001. Enforced expression of Gata-3 in transgenic mice inhibits Th1 differentiation and induces the formation of a T1/ST2-expressing Th2-committed T cell compartment in vivo. J. Immunol. 167:724-732.
34. Nawijn, M. C., et al. 2001. Enforced expression of GATA-3 during T cell development inhibits maturation of CD8 single-positive cells and induces thymic lymphoma in transgenic mice. J. Immunol. 167:715-723.
35. Okazaki, Y., et al. 2002. Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs. Nature 420:563-573.
36. Pai, S.-Y., M. L. Truitt, and I.-C. Ho. 2004. GATA-3 deficiency abrogates the development and maintenance of T helper type 2 cells. Proc. Natl. Acad. Sci. U. S. A. 101:1993-1998.
37. Pai, S.-Y., et al. 2003. Critical roles for transcription factor GATA-3 in thymocyte development. Immunity 19:863-875.
38. Sambandam, A., et al. 2005. Notch signaling controls the generation and differentiation of early T lineage progenitors. Nat. Immunol. 6:663-670.
39. Samson, S. I., et al. 2003. GATA-3 promotes maturation, IFN-gamma production, and liver-specific homing of NK cells. Immunity 19:701-711.
40. Taghon, T., et al. 2001. Enforced expression of GATA-3 severely reduces human thymic cellularity. J. Immunol. 167:4468-4475.
41. Taghon, T., M. A. Yui, and E. V. Rothenberg. 2007. Mast cell lineage diversion of T lineage precursors by the essential T cell transcription factor GATA-3. Nat. Immunol. 8:845-855.
42. Taylor, J., et al. 2006. ESPERR: learning strong and weak signals in genomic sequence alignments to identify functional elements. Genome Res. 16:1596- 1604.
43. Tsarovina, K., et al. 2010. The Gata3 transcription factor is required for the survival of embryonic and adult sympathetic neurons. J. Neurosci. 30:10833- 10843.
44. Tydell, C. C., et al. 2007. Molecular dissection of prethymic progenitor entry into the T lymphocyte developmental pathway. J. Immunol. 179:421-438.
45. van Hamburg, J. P., et al. 2008. Cooperation of Gata3, c-Myc and Notch in malignant transformation of double positive thymocytes. Mol. Immunol. 45:3085-3095.
46. Vosshenrich, C. A., et al. 2006. A thymic pathway of mouse natural killer cell development characterized by expression of GATA-3 and CD127. Nat. Immunol. 7:1217-1224.
47. Xi, H., et al. 2007. Identification and characterization of cell type-specific and ubiquitous chromatin regulatory structures in the human genome. PLoS Genet. 3:e136.
48. Xu, W., and B. L. Kee. 2007. Growth factor independent 1b (Gfi1b) is an E2A target gene that modulates Gata3 in T-cell lymphomas. Blood 109: 4406-4414.
49. Yamamoto, M., et al. 1990. Activity and tissue-specific expression of the transcription factor NF-E1 multigene family. Genes Dev. 4:1650-1662.
50. Yang, X. O., et al. 2009. Requirement for the basic helix-loop-helix transcription factor Dec2 in initial Th2 lineage commitment. Nat. Immunol. 10:1260-1266.
51. Yu, Q., et al. 2009. T cell factor 1 initiates the T helper type 2 fate by inducing the transcription factor GATA-3 and repressing interferon-gamma. Nat. Immunol. 10:992-999.
52. Zhang, D. H., L. Cohn, P. Ray, K. Bottomly, and A. Ray. 1997. Transcription factor GATA-3 is differentially expressed in murine Th1 and Th2 cells and controls Th2-specific expression of the interleukin-5 gene. J. Biol. Chem. 272:21597-21603.
53. Zheng, W., and R. A. Flavell. 1997. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89:587-596.
54. Zhu, J., et al. 2004. Conditional deletion of Gata3 shows its essential function in T(H)1-T(H)2 responses. Nat. Immunol. 5:1157-1165.